Estrella Immunopharma Files 8-K

Ticker: ESLAW · Form: 8-K · Filed: Feb 21, 2025 · CIK: 1844417

Estrella Immunopharma, INC. 8-K Filing Summary
FieldDetail
CompanyEstrella Immunopharma, INC. (ESLAW)
Form Type8-K
Filed DateFeb 21, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: 8-K, corporate-filing, financials

Related Tickers: ESLA

TL;DR

Estrella Immunopharma filed an 8-K on 2/21/25 for other events & financials. Nothing major.

AI Summary

Estrella Immunopharma, Inc. filed an 8-K on February 21, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The company, formerly known as TradeUP Acquisition Corp. until February 4, 2021, is based in Emeryville, CA, and operates in the Biological Products sector.

Why It Matters

This filing indicates routine corporate updates and the submission of financial documents, providing transparency to investors about the company's operational status.

Risk Assessment

Risk Level: low — The filing appears to be routine and does not disclose any significant negative events or material changes.

Key Numbers

Key Players & Entities

FAQ

What specific "Other Events" are being reported in this 8-K filing?

The provided text does not detail the specific "Other Events" beyond listing it as an item information category.

What are the key financial statements and exhibits included with this filing?

The filing lists "Financial Statements and Exhibits" as an item information category, but the specific documents are not detailed in the provided text.

When did Estrella Immunopharma, Inc. officially change its name from TradeUP Acquisition Corp.?

The company's name was changed from TradeUP Acquisition Corp. on February 4, 2021.

What is Estrella Immunopharma, Inc.'s primary business sector?

Estrella Immunopharma, Inc. operates in the Biological Products sector, specifically SIC code 2836.

What is the company's registered state of incorporation?

The company is incorporated in Delaware.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on February 21, 2025 regarding Estrella Immunopharma, Inc. (ESLAW).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing